Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.

Suppr

超能文献

作者信息

Jeste D V, Gilbert P L, McAdams L A, Harris M J

机构信息

Department of Psychiatry, University of California, San Diego.

出版信息

Arch Gen Psychiatry. 1995 Mar;52(3):209-12. doi: 10.1001/archpsyc.1995.03950150041008.

DOI:10.1001/archpsyc.1995.03950150041008

PMID:7872848

Abstract

摘要

相似文献

Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.

Arch Gen Psychiatry. 1995 Mar;52(3):209-12. doi: 10.1001/archpsyc.1995.03950150041008.

Why neuroleptic withdrawal in schizophrenia?

Arch Gen Psychiatry. 1995 Mar;52(3):192-3. doi: 10.1001/archpsyc.1995.03950150024003.

Neuroleptic withdrawal in schizophrenic patients.

Arch Gen Psychiatry. 1995 Mar;52(3):189-92. doi: 10.1001/archpsyc.1995.03950150021002.

Risks of withdrawing antipsychotic medications.

Arch Gen Psychiatry. 1995 Mar;52(3):205-8. doi: 10.1001/archpsyc.1995.03950150037007.

The early course of schizophrenia and long-term maintenance neuroleptic therapy.

Arch Gen Psychiatry. 1995 Mar;52(3):203-5. doi: 10.1001/archpsyc.1995.03950150035006.

Neuroleptic discontinuation and tardive dyskinesia risk.

Am J Psychiatry. 1999 Jul;156(7):1125-6. doi: 10.1176/ajp.156.7.1125a.

Neuroleptic withdrawal in schizophrenic patients. A review of the literature.

Arch Gen Psychiatry. 1995 Mar;52(3):173-88. doi: 10.1001/archpsyc.1995.03950150005001.

Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.

Arch Gen Psychiatry. 1995 Mar;52(3):200-2. doi: 10.1001/archpsyc.1995.03950150032005.

The treatment of tardive dyskinesia.

Schweiz Arch Neurol Psychiatr (1985). 1996;147(1):13-8.

Long-term treatment for lifetime disorders?

Arch Gen Psychiatry. 1995 Mar;52(3):197-200. doi: 10.1001/archpsyc.1995.03950150029004.

引用本文的文献

A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Psychiatry Res. 2017 Oct;256:267-274. doi: 10.1016/j.psychres.2017.06.069. Epub 2017 Jun 22.

Cost analysis of the treatment of schizophrenia in the UK: a comparison of olanzapine and haloperidol.

Pharmacoeconomics. 1998 May;13(5 Pt 2):575-88. doi: 10.2165/00019053-199813050-00010.

Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.

CNS Drugs. 2006;20(4):257-80. doi: 10.2165/00023210-200620040-00001.

The accuracy of medical record documentation in schizophrenia.

J Behav Health Serv Res. 2001 Nov;28(4):456-65. doi: 10.1007/BF02287775.

Ethical problems in psychiatric research.

J Ment Health Adm. 1997 Spring;24(2):227-50. doi: 10.1007/BF02898516.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.

Arch Gen Psychiatry. 1995 Mar;52(3):209-12. doi: 10.1001/archpsyc.1995.03950150041008.

Why neuroleptic withdrawal in schizophrenia?

Arch Gen Psychiatry. 1995 Mar;52(3):192-3. doi: 10.1001/archpsyc.1995.03950150024003.

Neuroleptic withdrawal in schizophrenic patients.

Arch Gen Psychiatry. 1995 Mar;52(3):189-92. doi: 10.1001/archpsyc.1995.03950150021002.

Risks of withdrawing antipsychotic medications.

Arch Gen Psychiatry. 1995 Mar;52(3):205-8. doi: 10.1001/archpsyc.1995.03950150037007.

The early course of schizophrenia and long-term maintenance neuroleptic therapy.

Arch Gen Psychiatry. 1995 Mar;52(3):203-5. doi: 10.1001/archpsyc.1995.03950150035006.

Neuroleptic discontinuation and tardive dyskinesia risk.

Am J Psychiatry. 1999 Jul;156(7):1125-6. doi: 10.1176/ajp.156.7.1125a.

Neuroleptic withdrawal in schizophrenic patients. A review of the literature.

Arch Gen Psychiatry. 1995 Mar;52(3):173-88. doi: 10.1001/archpsyc.1995.03950150005001.

Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.

Arch Gen Psychiatry. 1995 Mar;52(3):200-2. doi: 10.1001/archpsyc.1995.03950150032005.

The treatment of tardive dyskinesia.

Schweiz Arch Neurol Psychiatr (1985). 1996;147(1):13-8.

Long-term treatment for lifetime disorders?

Arch Gen Psychiatry. 1995 Mar;52(3):197-200. doi: 10.1001/archpsyc.1995.03950150029004.

引用本文的文献

A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Psychiatry Res. 2017 Oct;256:267-274. doi: 10.1016/j.psychres.2017.06.069. Epub 2017 Jun 22.

Cost analysis of the treatment of schizophrenia in the UK: a comparison of olanzapine and haloperidol.

Pharmacoeconomics. 1998 May;13(5 Pt 2):575-88. doi: 10.2165/00019053-199813050-00010.

Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.

CNS Drugs. 2006;20(4):257-80. doi: 10.2165/00023210-200620040-00001.

The accuracy of medical record documentation in schizophrenia.

J Behav Health Serv Res. 2001 Nov;28(4):456-65. doi: 10.1007/BF02287775.

Ethical problems in psychiatric research.

J Ment Health Adm. 1997 Spring;24(2):227-50. doi: 10.1007/BF02898516.